C12N 9/6435
Plasmin , i.e. fibrinolysin
Official title: {Plasmin (3.4.21.7), i.e. fibrinolysin}
C12N9/6435 (Plasmin , i.e. fibrinolysin) appears on 155 US grants and 155 published applications in this corpus.
Search patents in C12N- Granted patents
- 155
- Published applications
- 155
- Assignees
- 87
- Inventors
- 331
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 9 | 0 |
| 1999 | 8 | 0 |
| 2000 | 4 | 0 |
| 2001 | 7 | 3 |
| 2002 | 6 | 10 |
| 2003 | 4 | 11 |
| 2004 | 3 | 17 |
| 2005 | 4 | 3 |
| 2006 | 2 | 2 |
| 2007 | 1 | 5 |
| 2008 | 5 | 2 |
| 2009 | 5 | 5 |
| 2010 | 2 | 7 |
| 2011 | 3 | 6 |
| 2012 | 6 | 7 |
| 2013 | 4 | 7 |
| 2014 | 2 | 33 |
| 2015 | 11 | 2 |
| 2016 | 6 | 2 |
| 2017 | 5 | 6 |
| 2018 | 3 | 1 |
| 2019 | 4 | 6 |
| 2020 | 3 | 4 |
| 2021 | 1 | 3 |
| 2022 | 3 | 2 |
| 2023 | 5 | 4 |
| 2024 | 0 | 4 |
| 2025 | 2 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Plasminogen for use in treating and preventing lung dysfunction16 Dec 2025US 12,497,607 B2Previpharma Consulting GmbH
- Fibrinolytic composition and method of its preparation18 Feb 2025US 12,226,462 B2Council of Scientific and Industrial Research
- Preparing and use of Glu-plasminogen from blood fractions19 Sep 2023US 11,759,505 B2Previpharma Consulting GmbH
- Mirac proteins8 Aug 2023US 11,718,844 B2BioAtla, Inc.
- Pharmaceutical composition comprising plasminogen and uses thereof25 Apr 2023US 11,633,462 B2Prometic Biotherapeutics, Inc.
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Anti-cancer n-terminal fc conjugated immunotherapeutics5 Jun 2025US 2025/0179209 A1Immunofyx
- Modified polynucleotides for the production of biologics and proteins associated with human disease16 Jan 2025US 2025/0018062 A1Moderna TX, Inc.
- Process for isolating plasminogen from a blood plasma fraction8 Aug 2024US 2024/0262861 A1CSL Behring GmbH
- Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins25 Apr 2024US 2024/0131193 A1Modema TX, Inc.
Most cited
By later US patents
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Blood coagulation factors and process for their manufacture135US 4,297,344 ABehringwerke Aktiengesellschaft · 1981
- Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1124US 9,095,552 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding citeD4124US 9,114,113 B2Moderna Therapeutics, Inc. · 2015